Current Vascular Pharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q3 | 48.0% | 0.601 | Q2 | 67.7% |
| 2024 | 2.1 | Q3 | 47.5% | 0.726 | Q2 | 74.7% |
| 2023 | 2.8 | Q2 | 56.4% | 0.991 | Q1 | 85.3% |
| 2022 | 4.5 | Q2 | 77.7% | 0.917 | Q1 | 84.2% |
| 2021 | 3.5 | Q3 | 59.2% | 0.670 | Q2 | 76.2% |
| 2020 | — | — | 0.806 | Q2 | 79.9% | |
| 2019 | — | — | 0.559 | Q2 | 70.6% | |
| 2018 | — | — | 0.605 | Q2 | 71.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1875-6212
ISSN
1570-1611
country
AEcoverage
2003-2025